![](/img/cover-not-exists.png)
PP09.16 – 2691: Eteplirsen, a phosphorodiamidate morpholino oligomer (PMO) for the treatment of Duchenne muscular dystrophy (DMD): 3.2 year update on six-minute walk test (6MWT), pulmonary function testing (PFT), and safety
Kaye, E.M., Mendell, J.R., Rodino-Klapac, L., Sahenk, Z., Roush, K., Lowes, L.P., Alfano, L., Gomez, A.M., Malik, V., Flanigan, K.M., Shilling, C., Duda, P., Saoud, J.Volume:
19
Language:
english
Journal:
European Journal of Paediatric Neurology
DOI:
10.1016/S1090-3798(15)30228-2
Date:
May, 2015
File:
PDF, 91 KB
english, 2015